Nassim Morsli

Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study

M. Marty, Gregor Serša, Jean Rémi Garbay et al. · European Journal of Cancer Supplements · 2006 · 891 citations

Medicine, Dermatology, Oncology +10

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

Joaquim Bellmunt, Christine Théodore, T. Demkov et al. · Journal of Clinical Oncology · 2009 · 779 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Robert L. Ferris, Robert I. Haddad, Caroline Even et al. · Annals of Oncology · 2020 · 365 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

Amanda Psyrri, Jérôme Fayette, Kevin J. Harrington et al. · Annals of Oncology · 2022 · 144 citations · Full text

Medicine, Immunology, Oncology +17

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial

Federica Grosso, Nicola Steele, Silvia Novello et al. · Journal of Clinical Oncology · 2017 · 140 citations · Full text

Medicine, Oncology, Pharmacotherapy +14